Theodore Lystig
Overview
Explore the profile of Theodore Lystig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mikita J, Mitchel J, Gatto N, Laschinger J, Tcheng J, Zeitler E, et al.
Ther Innov Regul Sci
. 2020 Jun;
55(1):6-18.
PMID: 32572772
Background: Patient registries are organized systems that use observational methods to collect uniform data on specified outcomes in a population defined by a particular disease, condition, or exposure. Data collected...
2.
Celli B, Decramer M, Lystig T, Kesten S, Tashkin D
Respir Res
. 2012 Aug;
13:66.
PMID: 22866681
Background: The changes in inspiratory capacity (IC) over time in chronic obstructive pulmonary disease (COPD) patients are unknown. The Understanding Potential Long-term Impacts on Function with Tiotropium (UPLIFT®) trial included...
3.
Tashkin D, Celli B, Decramer M, Lystig T, Liu D, Kesten S
COPD
. 2012 Mar;
9(3):289-96.
PMID: 22432932
GOLD stage II COPD encompasses patients with FEV₁ 50-80% predicted. A published trials review suggested that benefits of maintenance therapy are limited to patients with FEV₁ <60% predicted. We previously...
4.
Decramer M, Molenberghs G, Liu D, Celli B, Kesten S, Lystig T, et al.
Respir Med
. 2011 May;
105(10):1523-30.
PMID: 21530213
Rationale: Placebo-controlled clinical trials on COPD are characterized by premature discontinuation. At present, no clear insight into this phenomenon is available. Objective: To obtain better insight into the phenomenon of...
5.
Olofsson L, Olsson B, Lystig T, Jacobson P, Jernas M, Sjoholm K, et al.
Metabolism
. 2010 Jan;
59(9):1316-8.
PMID: 20070991
Zn-alpha2-glycoprotein (ZAG) is a serum protein implicated in cancer cachexia and lipolysis. Our aim was to investigate serum levels of ZAG and polymorphisms in the ZAG gene in relation to...
6.
Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin D
Lancet
. 2009 Sep;
374(9696):1171-8.
PMID: 19716598
Background: The beneficial effects of pharmacotherapy for chronic obstructive pulmonary disease (COPD) are well established. However, there are few data for treatment in the early stages of the disease. We...
7.
Ruge T, Lockton J, Renstrom F, Lystig T, Sukonina V, Svensson M, et al.
Metabolism
. 2009 Apr;
58(6):860-6.
PMID: 19375766
Hyperinsulinemia is a characteristic of type 2 diabetes mellitus (T2DM) and is believed to play a role in the low-grade inflammation seen in T2DM. The main aim was to study...
8.
Alexanderson C, Eriksson E, Stener-Victorin E, Lystig T, Gabrielsson B, Lonn M, et al.
Endocrinology
. 2007 Jul;
148(11):5369-76.
PMID: 17656458
Postnatal events contribute to features of the metabolic syndrome in adulthood. In this study, postnatally administered testosterone reduced insulin sensitivity and increased the mesenteric fat depot, the size of mesenteric...
9.
Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, et al.
Endocrinology
. 2007 May;
148(8):3781-91.
PMID: 17495003
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder associated with ovulatory dysfunction, hyperandrogenism, abdominal obesity, and insulin resistance. However, its etiology is unclear, and its management is...